Skip to main content
FinSpry Logo
FinSpry
RGEN logo
RGEN
(NASDAQ)
Repligen Corporation
$167.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Repligen (RGEN) Stock Price & Financial Analysis

Repligen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$165.00 - $169.51
52-Week High$188.73
52-Week Low$100.99
Open$167.26
Volume806.06K
Average Volume (3M)1.09M
Market Cap9.49B
Shares Outstanding56.64M
P/E Ratio (TTM)228.52
Price to Sales (P/S)12.09
Price to Book (P/B)4.49
EV/EBITDA56.24
Revenue (TTM)785.10M
Net Income (TTM)41.54M
Free Cash Flow (TTM)110.54M
EPS (TTM)$0.73
Profit Margin5.29%
Operating Margin9.22%
Return on Equity (ROE)1.97%
Debt to Equity0.26
50-Day MA$155.63
200-Day MA$141.97
52-Week Change34.55%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Repligen

What is the current stock price for RGEN?

As of the latest trading session, RGEN stock trades at $167.60. The 52-week range is $100.99–$188.73, with a day range of $165.00–$169.51.

What is the P/E ratio for RGEN?

Repligen's trailing P/E ratio is 228.5, meaning investors pay $228.5 for every $1 of annual earnings. Repligen operates in the Healthcare sector.

Does RGEN pay dividends?

Repligen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RGEN?

Based on 4 analysts, the consensus for RGEN is Buy.

What is the market cap of RGEN?

Repligen's market capitalization is $9.49B, classifying it as a mid-cap company. Repligen operates in the Healthcare sector within the Medical Instruments & Supplies industry.